Kodak releases its Medical Imaging System
Kodak releases its Medical Imaging SystemEastman Kodak has begun shipments of its Kodak Distributed Medical Imaging system. The Rochester, NY-based company presented the system at last year’s RSNA show, and began receiving orders earlier
Kodak releases its Medical Imaging System
Eastman Kodak has begun shipments of its Kodak Distributed Medical Imaging system. The Rochester, NY-based company presented the system at last years RSNA show, and began receiving orders earlier this year (
PNN
1/99). It includes Kodak 1000 Distributed Medical Image Server, Kodak Distributed Medical Image Web viewers, three print spooler options, and two low-cost medical imagers, Kodak 3600 and 1200.
The vendor has also announced that it will be selling its laser imaging product line through selected x-ray products distributors, in addition to its own sales force and imaging modality manufacturers. The new network of x-ray distributors will market the Kodak DryView line of laser imagers and Kodak Ektascan 2180 laser printers.
In other Kodak news, subsidiary Cemax-Icon has appointed Ronald Heath as vice president of service. Heath joins Fremont, CA-based Cemax-Icon after more than 27 years of experience in the imaging market. He comes to the post from Acuson, where he was director of service, and will focus on boosting Cemax-Icons worldwide service and support team.
- Search again
- Homepage
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
